Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Internett]. 27. februar 2025 [sitert 24. august 2026];3(1). Tilgjengelig på: https://shmpublisher.com/index.php/johmpe/article/view/547